GF
IMUC

Gerstein Fisher’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Gerstein Fisher’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-325
Closed -$5K – 444
2015
Q4 		$5K Hold
325
– – ﹤0.01% 406
2015
Q3 		$5K Hold
325
– – ﹤0.01% 403
2015
Q2 		$6K Hold
325
– – ﹤0.01% 402
2015
Q1 		$6K Hold
325
– – ﹤0.01% 407
2014
Q4 		$9K Hold
325
– – ﹤0.01% 385
2014
Q3 		$12K Hold
325
– – ﹤0.01% 382
2014
Q2 		$15K Hold
325
– – ﹤0.01% 336
2014
Q1 		$16K Hold
325
– – ﹤0.01% 330
2013
Q4 		$12K Buy
325
+75
+30% +$7.1K ﹤0.01% 381
2013
Q3 		$26K Sell
250
-250
-50% -$27.4K 0.01% 360
2013
Q2 		$39K Buy
+500
New +$47.9K 0.01% 327

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return

Gerstein Fisher's IMUC Position: Q1 2016 in Review

Gerstein Fisher sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q1 2016, closing a stake of 325 shares — an estimated $5K sold.

Gerstein Fisher first reported a position in IMUC in Q2 2013 and held it in 11 quarters. The position peaked at $39K in Q2 2013. 34 funds tracked by Wall St. Rank hold IMUC as of Q1 2016.

  • Gerstein Fisher reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q1 2016 after selling out during the quarter.
  • Gerstein Fisher sold 325 ImmunoCellular Therapeutics, Ltd. shares in Q1 2016, an estimated $5K.
  • Gerstein Fisher first reported a position in ImmunoCellular Therapeutics, Ltd. in Q2 2013 and held it in 11 quarters.
  • Gerstein Fisher's ImmunoCellular Therapeutics, Ltd. position peaked at $39K in Q2 2013.
  • 34 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q1 2016.

Based on Gerstein Fisher's 13F filing for Q1 2016, filed 12 May 2016.